CClinicalTrials.gg
CompletedNCT02123719Updated Apr 25, 2014

Laparoscopic Incisional Hernia Repair in Liver Transplant Patients

An observational study in Hernia Recurrence Post Laparoscopic Incisional Hernia Repair in Liver Transplant Versus Non-transplant Patients., sponsored by Medical University Innsbruck. Completed at 1 site in Austria. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2014-04-25.

Sponsored by Medical University Innsbruck · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
112
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Retrospective analysis of patients undergoing laparoscopic incisional hernia repair.

Study group: Patients with incisional hernia post liver transplantation Control group: Patients with incisional hernia post any other laparotomy in the upper quadrant.

Primary study outcome parameter: Risk of hernia recurrence. Secondary study outcome parameters: - Hernia repair-related infection rate

  • Postoperative morbidity Statistical analysis: Comparison of study versus control group, univariate and multivariate analysis, Chi² and Mann-Whitney-U tests. P-values \<0.05 were considered significant.
02

Conditions studied

  • Hernia Recurrence Post Laparoscopic Incisional Hernia Repair in Liver Transplant Versus Non-transplant Patients.
03

In context

Recurrence

4,279 studies on the registry are indexed under Recurrence; 988 are open to participants now.

This study's enrollment of 112 is below the median of 200 across 702 observational studies indexed under Recurrence.

Browse Recurrence studies →

Lead sponsor

Medical University Innsbruck is the lead sponsor of 182 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient with incisional hernia post liver transplantation

Inclusion criteria

  • Incisional hernia
  • Laparoscopic repair possible

Exclusion criteria

Exclusion Criteria:

  • Other types of ventral hernias
  • Laparoscopy not possible
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
112 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients post liver transplantation

    Patients after liver transplantation

    Other: Surgery

  • Control group

    Patients with an abdominal incisional hernia without a history of immunosuppresion

    Other: Surgery

Interventions

  • OtherSurgery
06

What researchers measure

Primary outcomes

  1. Hernia recurrence post laparoscopic incisional hernia repair

    Time frame: 1 - 74 months post surgery

07

Study locations

1 site
  • Medical University Innsbruck
    Innsbruck, Tyrol 6020, Austria
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 25, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02123719
Lead sponsor
Medical University Innsbruck
Responsible party
Matthias Biebl (Priv.-Doz. M.D., Medical University Innsbruck) — Principal investigator
First posted
Apr 25, 2014
Start date
Jan 2013
Primary completion
Dec 2013
Completion
Feb 2014
Last update
Apr 25, 2014

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion